Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Media Resources
2014
Policy Brief 3 – Regulation of Mark-ups in the Pharmaceutical Supply Chain
Policy Brief 5 – Sales Taxes on Medicines
Policy Brief 2 – The Role of Health Insurance in the Cost-effective Use of Medicines
Working Paper 1 – External Reference Pricing
Policy Brief 4 – Competition Policy
Policy Brief 1 – External Reference Pricing
Working Paper 2 – The Role of Health Insurance in the Cost-Effective Use of Medicines
Working Paper 3: The Regulation of Mark-ups in the Pharmaceutical Supply Chain
Understanding and Responding To Medicines Promotion
2013
Transparency of Clinical Trial Data on Medicines in the EU
LAC-Global Alliance Statement on Trans-Pacific Partnership and Access to Affordable Medicines
NGOs Condemn the EU Press Release on TRIPS Extension for Least Developed Countries
Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique
EU-India free trade deal puts millions of lives at risk
2012 Annual Report
2012 Financial Statements
2012
ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
Time for the final push: Say “No” to ACTA – again
EU Parliament Says No and No Again to EMA: Independent Groups Echo Decision
Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs
Civil Society Calls on Members of the European Parliament to Condemn ACTA
Divide and Conquer: A look behind the scenes of the EU pharmaceutical industry lobby
Business Conduct Guidelines
Complaints Procedure (EN)
Unlocking the Mysteries of Access to Clinical Trials Data in the EU
2011